Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find out why SANA stock is a Strong Buy.

In the final analysis, the scope of any discipline/branch depends on employability. The engineers of the future will not be employed because they hold a degree in a certain branch they will be ...

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an ...

India’s net-zero energy future stands at the crossroads of two transformative visions — biofuel expansion and circular ...

The growth of the Global Optogenetics Equipment Market is driven by rising investments in neuroscience research, expanding applications in brain mapping, ...

Since 2019, breakthroughs in synthetic biology, AI-driven protein design, and precision fermentation have revitalized the ...

Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination ...

In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...

We are thrilled to welcome Matt to our leadership team,” said Allan Reine, M.D., Chief Executive Officer of Prime Medicine. “Business development has been – and will continue to be – a core pillar of ...

United States Adult Vaccine Market is expected to reach US$ 11.10 billion by 2033 from US$ 6.55 billion in 2024, with a CAGR of 6.03% from 2025 to 2033. Rising awareness, preventa ...

The Third Economic Forum on Genetic Resources, titled ‘GenoBusiness Forum’, highlighted the fundamentals of natural resources in Dhofar and called for necessary innovation to tap the resources. The ...